IM Cannabis Corp. (IMCC)
| Market Cap | 8.45M |
| Revenue (ttm) | 37.89M |
| Net Income (ttm) | -3.26M |
| Shares Out | 3.09M |
| EPS (ttm) | -1.27 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 17,411 |
| Open | 2.800 |
| Previous Close | 2.780 |
| Day's Range | 2.632 - 2.800 |
| 52-Week Range | 1.290 - 7.120 |
| Beta | 2.38 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2025 |
About IMCC
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel. [Read more]
Financial Performance
In 2024, IM Cannabis's revenue was 54.03 million, an increase of 10.71% compared to the previous year's 48.80 million. Losses were -10.59 million, 11.4% more than in 2023.
Financial numbers in CAD Financial StatementsNews
CSE Bulletin: Delist - IM Cannabis Corp. (IMCC)
Toronto, Ontario--(Newsfile Corp. - Le 28 mai/May 2025) - The common shares of IM Cannabis Corp. (the "Issuer") will be delisted from the CSE at market close, June 2, 2025. The Issuer will continue to...
IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange
TORONTO and GLIL YAM, Israel , May 28, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announces that it has appl...
IM Cannabis Provides Corporate Updates
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO and GLIL YAM, Israel...
IM Cannabis Corp. (IMCC) Q1 2025 Earnings Call Transcript
IM Cannabis Corp. (NASDAQ:IMCC) Q1 2025 Earnings Call May 15, 2025 9:00 AM ET Company Participants Anna Taranko - Director, Investor and Public Relations Oren Shuster - Chief Executive Officer Uri Bi...
IM Cannabis Reports First Quarter Financial Results
IMC Delivers Net Profit and 87% Gross Margin Improvement in Q1, Reflecting Strategic and Operational Progress TORONTO and GLIL YAM, Israel , May 15, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Compan...
IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction
TORONTO and GLIL YAM, Israel , May 7, 2025 /PRNewswire/ -- IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) (the "Company" or "IM Cannabis"), a leading medical cannabis company with operations in Israel a...
IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET
TORONTO and GLIL YAM, Israel , May 6, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in I...
IM Cannabis Corp. (IMCC) Q4 2024 Earnings Call Transcript
IM Cannabis Corp. (NASDAQ:IMCC) Q4 2024 Earnings Conference Call March 31, 2025 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chairman and Ch...
IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results
Q4 2024 Caps a Year of Strategic and Operational Improvements for IMC with 25% Revenue Growth, 42% decrease in Operating Expenses, and $0.5M Adjusted EBITDA Profit TORONTO and GLIL YAM, Israel , March...
IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET
TORONTO and GLIL YAM, Israel , March 20, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations i...
IM Cannabis Announces Change of Auditors
TORONTO and GLIL YAM, Israel, Jan. 17, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germ...
IM Cannabis Corp. (IMCC) Q3 2024 Earnings Call Transcript
IM Cannabis Corp. (NASDAQ:IMCC) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chief Execut...
IM Cannabis Reports Third Quarter Financial Results
IMC pairs a +12% increase in revenue with a -16% decrease in the total operating expenses, building a solid foundation to deliver in 2025. TORONTO and GLIL YAM, Israel , Nov. 14, 2024 /PRNewswire/ -- ...
IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET
TORONTO and GLIL YAM, Israel , Nov. 6, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in ...
IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO and GLIL YAM, Israel...
IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2
TORONTO and GLIL YAM, Israel , Oct. 2, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in ...
IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors
TORONTO and GLIL YAM, Israel , Sept. 11, 2024 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and G...
IM Cannabis Corp. (IMCC) Q2 2024 Earnings Call Transcript
IM Cannabis Corp. (NASDAQ:IMCC) Q2 2024 Earnings Conference Call August 14, 2024 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chief Executiv...
IM Cannabis Reports Second Quarter Financial Results
IMC Germany delivers +200% in sales in first three months after German legalization, while overall revenue grows 12% vs Q2 2023 TORONTO and GLIL YAM, Israel, Aug. 14, 2024 /PRNewswire/ -- IM Cannabis ...
IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET
TORONTO and GLIL YAM, Israel , Aug. 6, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in ...
IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement
TORONTO and GLIL YAM, Israel , July 29, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in...
IM Cannabis Shares Surge 586% After 6:1 Consolidation: What Investors Need To Know
IM Cannabis Corp. IMCC, a leading medical marijuana company announced that its common shares are trading on a 6:1 post-consolidated basis.
IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis
TORONTO and GLIL YAM, Israel , July 12, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IM Cannabis"), a leading medical cannabis company with operations in Israel...
CSE Bulletin: Consolidation - IM Cannabis Corp. (IMCC)
Toronto, Ontario--(Newsfile Corp. - Le 9 juillet/July 2024) - IM Cannabis Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated comm...
IM Cannabis Announces Intention to Complete Consolidation
TORONTO and GLIL YAM, Israel, July 5, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in ...